Detalhe da pesquisa
1.
Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens.
Mol Cell
; 83(15): 2792-2809.e9, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478847
2.
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
Cell
; 159(3): 499-513, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25417103
3.
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Mol Cell
; 81(15): 3128-3144.e7, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216544
4.
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Mol Cell
; 81(22): 4692-4708.e9, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555355
5.
PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.
EMBO J
; 43(6): 1015-1042, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360994
6.
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature
; 608(7923): 609-617, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948633
7.
TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development.
Genes Dev
; 34(3-4): 179-193, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879358
8.
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis.
Nature
; 572(7770): 538-542, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367040
9.
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers.
Breast Cancer Res
; 26(1): 29, 2024 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38374113
10.
In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.
EMBO J
; 39(5): e102169, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930530
11.
The shieldin complex mediates 53BP1-dependent DNA repair.
Nature
; 560(7716): 117-121, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30022168
12.
HELB Is a Feedback Inhibitor of DNA End Resection.
Mol Cell
; 61(3): 405-418, 2016 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26774285
13.
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Mol Cell
; 81(15): 3227, 2021 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358459
14.
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.
Genes Dev
; 30(12): 1470-80, 2016 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27340177
15.
Fourteenth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer.
J Mammary Gland Biol Neoplasia
; 28(1): 22, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801168
16.
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research.
J Mammary Gland Biol Neoplasia
; 28(1): 17, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450065
17.
Long-term expanding human airway organoids for disease modeling.
EMBO J
; 38(4)2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643021
18.
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.
Cell
; 133(4): 727-41, 2008 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-18485879
19.
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature
; 609(7929): E13, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050473
20.
Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate.
Mol Cell Proteomics
; 20: 100078, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819647